1.Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
Jae Hyeok CHOI ; Jong Won KIM ; Joo Yong LEE ; Woong Kyu HAN ; Koon Ho RHA ; Young Deuk CHOI ; Sung Joon HONG ; Young Eun YOON
Korean Journal of Urology 2015;56(10):695-702
PURPOSE: To investigate and distinguish the computed tomography (CT) characteristics of chromophobe renal cell carcinoma (chRCC) and renal oncocytoma. MATERIALS AND METHODS: Fifty-one patients with renal oncocytoma and 120 patients with chRCC, diagnosed by surgery between November 2005 and June 2015, were studied retrospectively. Two observers, who were urologists and unaware of the pathological results, reviewed the preoperative CT images. The tumors were evaluated for size, laterality, tumor type (ball or bean pattern), central stellate scar, segmental enhancement inversion, and angular interface pattern and tumor complexity. To accurately analyze the mass-enhancing pattern of renal mass, we measured Hounsfield units (HUs) in each phase and analyzed the mean, maximum, and minimum HU values and standard deviations. RESULTS: There were 51 renal oncocytomas and 120 chRCCs in the study cohort. No differences in clinical and demographic characteristics were observed between the two groups. A central stellate scar and segmental enhancement inversion were more likely in oncocytomas. However, there were no differences in ball-/bean-type categorization, enhancement pattern, and the shape of the interface between the groups. Higher HU values tended to be present in the corticomedullary and nephrogenic phases in oncocytomas than in chRCC. Receiver-operating characteristic curve analysis showed that the presence of a central stellate scar and higher mean HU values in the nephrogenic phase were highly predictive of renal oncocytoma (area under the curve=0.817, p<0.001). CONCLUSIONS: The appearance of a central stellate scar and higher mean HU values in the nephrogenic phase could be useful to distinguish renal oncocytomas from chRCCs.
Adenoma, Oxyphilic/pathology/*radiography
;
Carcinoma, Renal Cell/pathology/*radiography
;
Diagnosis, Differential
;
Female
;
Humans
;
Kidney Neoplasms/pathology/*radiography
;
Male
;
Middle Aged
;
Retrospective Studies
;
Tomography, X-Ray Computed
2.Computed Tomography and Magnetic Resonance Images of Adrenocortical Oncocytoma Cases.
Jung Hee YOON ; Seong Sook CHA ; Seong Kuk YOON
Journal of Korean Medical Science 2014;29(3):445-451
We present two cases of adrenocortical oncocytomas that were well-delineated on multi-detector computed tomography and magnetic resonance imaging. The images showed a well-enhanced large mass with multiple stippled calcifications in a 10-yr-old girl who was consulted due to precocious puberty. A well-enhanced solid mass with necrotic components was incidentally noticed in a 54-yr-old man. These lesions were resected and diagnosed as adrenocortical oncocytomas through immunohistochemical studies and electron microscopy. Adrenocortical oncocytomas are rare disease entities, therefore, we report these interesting, rare adrenocortical oncocytomas here with radiologic findings, and discuss differential diagnosis.
Adenoma, Oxyphilic/*diagnosis/pathology/radiography
;
Adrenal Gland Neoplasms/*diagnosis/pathology/radiography
;
Child
;
Diagnosis, Differential
;
Female
;
Hemorrhage
;
Humans
;
Immunohistochemistry
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Tomography, X-Ray Computed
3.Imaging Findings of Common Benign Renal Tumors in the Era of Small Renal Masses: Differential Diagnosis from Small Renal Cell Carcinoma: Current Status and Future Perspectives.
Korean Journal of Radiology 2015;16(1):99-113
The prevalence of small renal masses (SRM) has risen, paralleling the increased usage of cross-sectional imaging. A large proportion of these SRMs are not malignant, and do not require invasive treatment such as nephrectomy. Therefore, differentation between early renal cell carcinoma (RCC) and benign SRM is critical to achieve proper management. This article reviews the radiological features of benign SRMs, with focus on two of the most common benign entities, angiomyolipoma and oncocytoma, in terms of their common imaging findings and differential features from RCC. Furthermore, the role of percutaneous biopsy is discussed as imaging is yet imperfect, therefore necessitating biopsy in certain circumstances to confirm the benignity of SRMs.
Abdominal Fat/pathology
;
Adenoma, Oxyphilic/diagnosis/radiography/ultrasonography
;
Angiomyolipoma/diagnosis/radiography/ultrasonography
;
Carcinoma, Renal Cell/*diagnosis/radiography/ultrasonography
;
Diagnosis, Differential
;
Humans
;
Kidney Neoplasms/*diagnosis/*radiography/ultrasonography
;
Leiomyoma/diagnosis/radiography/ultrasonography